|
|
 | | | |
- close
- close
- close
- close
Electro-Optical Sciences (MELA) |
QUOTE AND NEWS
Globe Newswire
May 4
Comment
ADVISORY, May 4, 2012 (GLOBE NEWSWIRE) -- What: MELA Sciences, Inc. [MELA], the medical device company that has developed MelaFind®,will visit the NASDAQ MarketSite in Times Square in recognition of Melanoma Monday® and to kick-off Melanoma/Skin
Marketwire
May 3
Comment
IRVINGTON, NY -- (Marketwire) -- 05/03/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced financial results for the first quarter ended March 31, 2012. First Quarter 2012 Performance
Marketwire
Apr 27
Comment
IRVINGTON, NY -- (Marketwire) -- 04/27/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, announced today that it was named a bronze Edison Award winner for MelaFind, a non-invasive, objective,
Marketwire
Apr 24
Comment
IRVINGTON, NY -- (Marketwire) -- 04/24/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that Joseph V. Gulfo, MD, President and CEO, will be presenting at the 37th Annual Deutsche
Marketwire
Apr 23
Comment
IRVINGTON, NY -- (Marketwire) -- 04/23/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that it will host a meeting for investors and analysts on Monday, May 7, 2012, 10-11 AM ET in
Marketwire
Apr 16
Comment
IRVINGTON, NY -- (Marketwire) -- 04/16/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that it will release its 2012 first quarter financial results after the close of trading on
Marketwire
Mar 26
Comment
IRVINGTON, NY -- (Marketwire) -- 03/26/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that Joseph V. Gulfo, MD, President and CEO, will be presenting at an upcoming investor
Marketwire
Mar 22
Comment
IRVINGTON, NY -- (Marketwire) -- 03/22/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that the company has entered into a two-year agreement with Quintiles (Quintiles Commercial
Benzinga
Mar 8
Comment
Shares of MELA Sciences (NASDAQ: MELA) are lower on the session by 2.73%, currently trading at $4.64. The stock has been moving largely higher over the past two months and is currently trading above the 50-day moving average.
Options traders...
Marketwire
Mar 7
Comment
IRVINGTON, NY -- (Marketwire) -- 03/07/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that the company has commenced commercialization of MelaFind as part of a controlled and
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
